Mediolanum International Funds Ltd Sells 359 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mediolanum International Funds Ltd decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,233 shares of the company’s stock after selling 359 shares during the quarter. Mediolanum International Funds Ltd’s holdings in HCA Healthcare were worth $3,501,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $1,021,000. American Century Companies Inc. boosted its holdings in shares of HCA Healthcare by 36.9% during the 4th quarter. American Century Companies Inc. now owns 31,962 shares of the company’s stock worth $9,593,000 after buying an additional 8,623 shares during the period. LPL Financial LLC raised its holdings in HCA Healthcare by 21.2% in the 4th quarter. LPL Financial LLC now owns 61,581 shares of the company’s stock worth $18,484,000 after acquiring an additional 10,777 shares during the period. Congress Wealth Management LLC DE grew its position in shares of HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock valued at $312,000 after purchasing an additional 34 shares during the last quarter. Finally, WINTON GROUP Ltd acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $270,000. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. Stephens upgraded HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Robert W. Baird restated a “neutral” rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an “overweight” rating in a research note on Monday, June 2nd. Bank of America cut HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 price target for the company. in a report on Wednesday, July 16th. Finally, Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the company an “equal weight” rating in a research note on Monday, June 9th. Eight investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $399.46.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by company insiders.

HCA Healthcare Trading Down 2.1%

Shares of HCA stock opened at $334.26 on Monday. The company has a market capitalization of $80.41 billion, a P/E ratio of 14.05, a P/E/G ratio of 1.15 and a beta of 1.47. The firm has a 50-day moving average price of $373.81 and a 200 day moving average price of $346.16. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $5.50 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.